Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Beacon Therapeutics (United States)
Homepage:
beacontx.com
Alternate names:
Beacon Therapeutics,
Beacon Therapeutics Holdings Limited,
Beacon Therapeutics Limited,
Beacon Therapeutics Ltd.
ROR:
03y77z015
OpenAlex ID:
I4405267698
Clinical Validation of a Circulating Tumor DNA–Based Blood Test to Screen for Colorectal Cancer
2025
·
Aasma Shaukat
, Carol A. Burke
, et al.
·
JAMA
·
75
Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results
2024
·
Paul Yang
, David Birch
, et al.
·
American Journal of Ophthalmology
·
34
Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States
2026
·
Aaron Nagiel
, Stephen R. Russell
, et al.
·
Ophthalmology
·
3
PDF
Addressing Multiplicity in Retinal Sensitivity Analysis: An Alternative Approach to Assessing Gene Therapy Efficacy in Inherited Retinal Diseases
2025
·
Antonio Yaghy
, David G. Birch
, et al.
·
Translational Vision Science & Technology
·
3
Three-dimensional Hill of Vision of Retinal Sensitivity in Participants With X-linked Retinitis Pigmentosa Under Scotopic and Mesopic Conditions
2024
·
Antonio Yaghy
, A. Yasin Alibhai
, et al.
·
Retina
·
1
Show more works
View as search
Works count:
5
Citation count:
266
Year
Topic
Type
